Annual D&A
$177.57 M
+$19.97 M+12.67%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual depreciation & amortization is currently $177.57 million, with the most recent change of +$19.97 million (+12.67%) on 31 March 2024. During the last 3 years, it has risen by +$5.52 million (+3.21%). RDY annual D&A is now -2.24% below its all-time high of $181.63 million, reached on 31 March 2018.RDY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$47.26 M
+$1.59 M+3.48%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly depreciation & amortization is currently $47.26 million, with the most recent change of +$1.59 million (+3.48%) on 01 September 2024. Over the past year, it has increased by +$1.71 million (+3.76%). RDY quarterly D&A is now -2.12% below its all-time high of $48.28 million, reached on 31 March 2019.RDY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$183.21 M
+$1.71 M+0.94%
01 September 2024
Summary:
Dr Reddys Laboratories Limited TTM depreciation & amortization is currently $183.21 million, with the most recent change of +$1.71 million (+0.94%) on 01 September 2024. Over the past year, it has increased by +$14.03 million (+8.30%). RDY TTM D&A is now at all-time high.RDY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.7% | +3.8% | +8.3% |
| 3 y3 years | +3.2% | +17.9% | +10.7% |
| 5 y5 years | +1.9% | +1.0% | +1.8% |
RDY Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +12.7% | at high | +25.6% | at high | +17.8% |
| 5 y | 5 years | at high | +12.7% | at high | +25.6% | at high | +17.8% |
| alltime | all time | -2.2% | +809.6% | -2.1% | +945.7% | at high | +3658.2% |
Dr Reddys Laboratories Limited Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $47.26 M(+3.5%) | $183.21 M(+0.9%) |
| June 2024 | - | $45.67 M(+0.1%) | $181.50 M(+1.2%) |
| Mar 2024 | $177.57 M(+12.7%) | $45.63 M(+2.2%) | $179.27 M(+1.7%) |
| Dec 2023 | - | $44.66 M(-1.9%) | $176.21 M(+4.2%) |
| Sept 2023 | - | $45.55 M(+4.8%) | $169.18 M(+4.7%) |
| June 2023 | - | $43.44 M(+2.1%) | $161.51 M(+2.5%) |
| Mar 2023 | $157.60 M(-0.7%) | $42.56 M(+13.1%) | $157.60 M(+1.4%) |
| Dec 2022 | - | $37.63 M(-0.7%) | $155.49 M(-0.7%) |
| Sept 2022 | - | $37.88 M(-4.2%) | $156.65 M(-1.4%) |
| June 2022 | - | $39.53 M(-2.3%) | $158.87 M(+0.1%) |
| Mar 2022 | $158.73 M(-7.7%) | $40.45 M(+4.3%) | $158.73 M(-0.9%) |
| Dec 2021 | - | $38.78 M(-3.3%) | $160.16 M(-3.2%) |
| Sept 2021 | - | $40.10 M(+1.8%) | $165.53 M(-2.8%) |
| June 2021 | - | $39.39 M(-6.0%) | $170.23 M(-1.1%) |
| Mar 2021 | $172.05 M(-2.0%) | $41.89 M(-5.1%) | $172.05 M(-0.2%) |
| Dec 2020 | - | $44.16 M(-1.4%) | $172.46 M(+1.1%) |
| Sept 2020 | - | $44.79 M(+8.7%) | $170.58 M(-1.2%) |
| June 2020 | - | $41.22 M(-2.5%) | $172.59 M(-1.7%) |
| Mar 2020 | $175.63 M(+0.8%) | $42.29 M(+0.0%) | $175.63 M(-3.3%) |
| Dec 2019 | - | $42.28 M(-9.7%) | $181.62 M(+0.9%) |
| Sept 2019 | - | $46.81 M(+5.8%) | $180.06 M(+3.5%) |
| June 2019 | - | $44.25 M(-8.4%) | $174.01 M(-0.1%) |
| Mar 2019 | $174.26 M(-4.1%) | $48.28 M(+18.6%) | $174.26 M(+0.8%) |
| Dec 2018 | - | $40.73 M(-0.1%) | $172.95 M(-2.6%) |
| Sept 2018 | - | $40.75 M(-8.4%) | $177.60 M(-2.8%) |
| June 2018 | - | $44.50 M(-5.3%) | $182.74 M(+0.6%) |
| Mar 2018 | $181.63 M(+8.0%) | $46.97 M(+3.5%) | $181.63 M(+2.1%) |
| Dec 2017 | - | $45.37 M(-1.1%) | $177.92 M(+1.7%) |
| Sept 2017 | - | $45.89 M(+5.7%) | $174.87 M(+2.0%) |
| June 2017 | - | $43.40 M(+0.3%) | $171.50 M(+2.0%) |
| Mar 2017 | $168.17 M(+7.3%) | $43.27 M(+2.2%) | $168.17 M(-1.5%) |
| Dec 2016 | - | $42.32 M(-0.5%) | $170.71 M(+2.6%) |
| Sept 2016 | - | $42.51 M(+6.1%) | $166.37 M(+3.3%) |
| June 2016 | - | $40.07 M(-12.5%) | $161.01 M(+2.8%) |
| Mar 2016 | $156.69 M(+18.2%) | $45.80 M(+20.6%) | $156.69 M(+5.4%) |
| Dec 2015 | - | $37.98 M(+2.2%) | $148.63 M(+4.5%) |
| Sept 2015 | - | $37.15 M(+3.9%) | $142.24 M(+3.9%) |
| June 2015 | - | $35.75 M(-5.3%) | $136.97 M(+3.4%) |
| Mar 2015 | $132.51 M(+12.4%) | $37.74 M(+19.5%) | $132.51 M(+2.1%) |
| Dec 2014 | - | $31.59 M(-0.9%) | $129.82 M(+2.0%) |
| Sept 2014 | - | $31.88 M(+1.9%) | $127.23 M(+5.8%) |
| June 2014 | - | $31.30 M(-10.7%) | $120.26 M(+2.0%) |
| Mar 2014 | $117.93 M(+15.5%) | $35.05 M(+20.9%) | $117.93 M(+7.1%) |
| Dec 2013 | - | $29.00 M(+16.4%) | $110.11 M(+2.4%) |
| Sept 2013 | - | $24.91 M(-14.0%) | $107.55 M(+0.5%) |
| June 2013 | - | $28.97 M(+6.4%) | $107.01 M(+4.8%) |
| Mar 2013 | $102.10 M | $27.24 M(+3.0%) | $102.10 M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | $26.43 M(+8.5%) | $109.05 M(+6.0%) |
| Sept 2012 | - | $24.37 M(+1.3%) | $102.92 M(-2.6%) |
| June 2012 | - | $24.06 M(-29.6%) | $105.71 M(-3.2%) |
| Mar 2012 | $109.25 M(+19.9%) | $34.19 M(+68.5%) | $109.25 M(+12.4%) |
| Dec 2011 | - | $20.30 M(-25.3%) | $97.17 M(-5.0%) |
| Sept 2011 | - | $27.16 M(-1.6%) | $102.27 M(+5.1%) |
| June 2011 | - | $27.60 M(+24.8%) | $97.31 M(+6.8%) |
| Mar 2011 | $91.11 M(+3.7%) | $22.11 M(-12.9%) | $91.11 M(+2.4%) |
| Dec 2010 | - | $25.40 M(+14.4%) | $88.99 M(+1.6%) |
| Sept 2010 | - | $22.20 M(+3.7%) | $87.56 M(+1.9%) |
| June 2010 | - | $21.40 M(+7.1%) | $85.94 M(-2.1%) |
| Mar 2010 | $87.83 M(+5.7%) | $19.99 M(-16.6%) | $87.83 M(-5.0%) |
| Dec 2009 | - | $23.98 M(+16.5%) | $92.46 M(+11.1%) |
| Sept 2009 | - | $20.58 M(-11.6%) | $83.24 M(-0.9%) |
| June 2009 | - | $23.29 M(-5.4%) | $84.00 M(+1.1%) |
| Mar 2009 | $83.10 M(-0.9%) | $24.62 M(+67.0%) | $83.10 M(+1.3%) |
| Dec 2008 | - | $14.75 M(-30.9%) | $82.01 M(-7.8%) |
| Sept 2008 | - | $21.34 M(-4.7%) | $88.95 M(+0.8%) |
| June 2008 | - | $22.40 M(-4.8%) | $88.24 M(+5.2%) |
| Mar 2008 | $83.89 M(+25.3%) | $23.53 M(+8.5%) | $83.89 M(+6.8%) |
| Dec 2007 | - | $21.68 M(+5.1%) | $78.53 M(+6.8%) |
| Sept 2007 | - | $20.63 M(+14.3%) | $73.51 M(+6.7%) |
| June 2007 | - | $18.05 M(-0.6%) | $68.88 M(+2.9%) |
| Mar 2007 | $66.97 M(+88.1%) | $18.17 M(+9.1%) | $66.97 M(+11.2%) |
| Dec 2006 | - | $16.66 M(+4.1%) | $60.20 M(+17.9%) |
| Sept 2006 | - | $16.00 M(-0.8%) | $51.07 M(+18.1%) |
| June 2006 | - | $16.14 M(+41.6%) | $43.25 M(+21.5%) |
| Mar 2006 | $35.61 M(+21.8%) | $11.40 M(+51.3%) | $35.61 M(+5.8%) |
| Dec 2005 | - | $7.53 M(-7.9%) | $33.65 M(+3.8%) |
| Sept 2005 | - | $8.18 M(-3.7%) | $32.43 M(+4.2%) |
| June 2005 | - | $8.50 M(-10.0%) | $31.13 M(+6.5%) |
| Mar 2005 | $29.24 M(+18.7%) | $9.44 M(+49.6%) | $29.24 M(+11.5%) |
| Dec 2004 | - | $6.31 M(-8.3%) | $26.22 M(-0.3%) |
| Sept 2004 | - | $6.88 M(+4.2%) | $26.30 M(+3.1%) |
| June 2004 | - | $6.61 M(+2.8%) | $25.52 M(+3.6%) |
| Mar 2004 | $24.62 M(+17.5%) | $6.42 M(+0.6%) | $24.62 M(+5.0%) |
| Dec 2003 | - | $6.38 M(+4.6%) | $23.45 M(+4.4%) |
| Sept 2003 | - | $6.10 M(+6.8%) | $22.47 M(+5.4%) |
| June 2003 | - | $5.71 M(+8.7%) | $21.32 M(+1.7%) |
| Mar 2003 | $20.96 M(+5.9%) | $5.25 M(-2.7%) | $20.96 M(-1.5%) |
| Dec 2002 | - | $5.40 M(+9.0%) | $21.28 M(+4.3%) |
| Sept 2002 | - | $4.95 M(-7.4%) | $20.40 M(+0.7%) |
| June 2002 | - | $5.35 M(-4.2%) | $20.26 M(+2.4%) |
| Mar 2002 | $19.79 M(+1.4%) | $5.58 M(+23.5%) | $19.79 M(+39.3%) |
| Dec 2001 | - | $4.52 M(-6.1%) | $14.21 M(+46.6%) |
| Sept 2001 | - | $4.81 M(-1.3%) | $9.69 M(+98.7%) |
| June 2001 | - | $4.88 M | $4.88 M |
| Mar 2001 | $19.52 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual depreciation & amortization?
- What is the all time high annual D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual D&A year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly D&A year-on-year change?
- What is Dr Reddys Laboratories Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM D&A year-on-year change?
What is Dr Reddys Laboratories Limited annual depreciation & amortization?
The current annual D&A of RDY is $177.57 M
What is the all time high annual D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual depreciation & amortization is $181.63 M
What is Dr Reddys Laboratories Limited annual D&A year-on-year change?
Over the past year, RDY annual depreciation & amortization has changed by +$19.97 M (+12.67%)
What is Dr Reddys Laboratories Limited quarterly depreciation & amortization?
The current quarterly D&A of RDY is $47.26 M
What is the all time high quarterly D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly depreciation & amortization is $48.28 M
What is Dr Reddys Laboratories Limited quarterly D&A year-on-year change?
Over the past year, RDY quarterly depreciation & amortization has changed by +$1.71 M (+3.76%)
What is Dr Reddys Laboratories Limited TTM depreciation & amortization?
The current TTM D&A of RDY is $183.21 M
What is the all time high TTM D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM depreciation & amortization is $183.21 M
What is Dr Reddys Laboratories Limited TTM D&A year-on-year change?
Over the past year, RDY TTM depreciation & amortization has changed by +$14.03 M (+8.30%)